Placement Completed

Neurizon Therapeutics placement

A$24.2m raised

Announced 23 Dec 2025 · ASX: NUZ · A$0.08 cash per share

Advisers

Neurizon Therapeutics

Issuer

Not disclosed

Lead managers

Lead manager
Bookrunner
Issuer
Neurizon Therapeutics
Completed
31 Dec 2025
Sector
Biotech and pharmaceuticals

Similar deals

All health care deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.